Preferred Label : Pulmonary venoocclusive disease 1, autosomal dominant;
Symbol : PVOD1;
CISMeF acronym : PVOD; PVOD1;
Type : Phenotype, molecular basis known;
Alternative titles and symbols : PVOD;
Description : Pulmonary venoocclusive disease primarily affects the postcapillary venous pulmonary
vessels and may involve significant pulmonary capillary dilation and/or proliferation.
PVOD is an uncommon cause of pulmonary artery hypertension (PAH; 178600), a severe
condition characterized by elevated pulmonary artery pressure leading to right heart
failure and death. PVOD accounts for 5 to 10% of 'idiopathic' PAH and has an estimated
incidence of 0.1 to 0.2 cases per million. The pathologic hallmark of PVOD is the
extensive and diffuse occlusion of pulmonary veins by fibrous tissue, with intimal
thickening present in venules and small veins in lobular septa and, rarely, larger
veins. Definitive diagnosis of PVOD requires histologic analysis of a lung sample,
although surgical lung biopsy is often too invasive for these frail patients. Patients
with PVOD respond poorly to available therapy, therefore it is crucial to distinguish
PVOD from other forms of PAH. Radiologic characteristics suggestive of PVOD on high-resolution
CT of the chest include nodular ground-glass opacities, septal lines, and lymph node
enlargement. In addition, because PVOD mainly affects postcapillary vasculature, it
causes chronic elevation of pulmonary capillary pressure and thus promotes occult
alveolar hemorrhage, which may be a characteristic feature of PVOD (summary by Montani
et al., 2008).;
Inheritance : Autosomal dominant;
Molecular basis : Caused by mutation in the bone morphogenetic receptor, type II gene (BMPR2, 600799.0001);
Prefixed ID : #265450;
Origin ID : 265450;
UMLS CUI : C3887658;
Currated CISMeF NLP mapping
DO Cross reference
Genes related to phenotype
HPO term(s)
ORDO concept(s)
Semantic type(s)
Validated automatic mappings to NTBT